MAGEC2 and breast cancer: Overall, this study suggests that the aberrant expression of MAGEC2 and presumably related cancer-testis antigens in malignant solid tumors is triggered at least in part by the gradual increase in circulating Ca2+ that develops as breast cancer progresses to more malignant stages.